Catalyst Wire Dossier Catalyst Wire Dossier

Docetaxel Kabi

docetaxel · Fresenius Kabi Deutschland GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Docetaxel Kabi, covering 2025-08-04 to 2026-08-06. Get the full timeline:

Most recent: EMA Authorised: Docetaxel Kabi (docetaxel) — Fresenius Kabi Deutschland GmbH

See pricing